Amedeo Smart

Free Medical Literature Service

 

Amedeo

Valvular Heart Disease
  Free Subscription

Articles published in
Int J Cardiol
    June 2024
  1. PARATZ ED, Stub D, Sutherland N, Gutman S, et al
    Response to: Regard to assessing agreement between two raters with kappa statistics.
    Int J Cardiol. 2024;404:131978.
    >> Share

  2. GESKE JB, Schaff HV
    Role of experience in myectomy for hypertrophic cardiomyopathy: With very high procedural volume, myectomy remains low-risk even with concomitant procedure need.
    Int J Cardiol. 2024;404:131961.
    >> Share

  3. ANG SP, Chia JE
    Reevaluating female survival benefit in TAVR: A closer look in the current era.
    Int J Cardiol. 2024;404:131935.
    >> Share

    May 2024
  4. ALPERI A, Pascual I, Moris C, Avanzas P, et al
    Neo 2 transcatheter heart valve system: Direct towards a minimalistic procedure.
    Int J Cardiol. 2024;402:131883.
    >> Share

  5. VESELKA J
    Estimating the risk of sudden death in hypertrophic cardiomyopathy might be solved by artificial intelligence.
    Int J Cardiol. 2024;402:131842.
    >> Share

    April 2024
  6. PRAKASH SK
    Editorial on Bellino et al., "Aortopathy and aortic valve surgery in patients with bicuspid aortic valve with and without raphe".
    Int J Cardiol. 2024 Apr 16:132047. doi: 10.1016/j.ijcard.2024.132047.
    >> Share

  7. CHENG Y, Zhang Q
    Commentary on the mitral regurgitation outcomes after transcatheter atrial septal defect closure.
    Int J Cardiol. 2024 Apr 6:132033. doi: 10.1016/j.ijcard.2024.132033.
    >> Share

  8. ALTIBI AM, Sapru A, Ghanem F, Zhao Y, et al
    Impact of concomitant surgical interventions on outcomes of septal myectomy in obstructive hypertrophic cardiomyopathy.
    Int J Cardiol. 2024;400:131790.
    >> Share

  9. DE SA MARCHI MF, van den Dorpel M, Calomeni P, Chatterjee S, et al
    Comparative analysis of different risk prediction tools after mitral Transcatheter edge-to-edge repair.
    Int J Cardiol. 2024;400:131768.
    >> Share

    March 2024
  10. SANG SLW, Weissman C, Parker J, Timek T, et al
    Contemporary outcomes of surgical aortic valve replacement in patients referred for a transcatheter approach.
    Int J Cardiol. 2024 Mar 30:132004. doi: 10.1016/j.ijcard.2024.132004.
    >> Share

  11. BELLINO M, Antonini-Canterin F, Bossone E, Faggiano P, et al
    Aortopathy and aortic valve surgery in patients with bicuspid aortic valve with and without raphe.
    Int J Cardiol. 2024 Mar 30:132000. doi: 10.1016/j.ijcard.2024.132000.
    >> Share

  12. BLEIZIFFER S, Appleby C, Delgado V, Eltchaninoff H, et al
    Patterns of aortic valve replacement in Europe and adoption by sex.
    Int J Cardiol. 2024 Mar 28:131996. doi: 10.1016/j.ijcard.2024.131996.
    >> Share

  13. KALKAN S, Gursoy MO, Guner A, Kalcik M, et al
    Management of prosthetic valve thrombosis with unfractionated heparin.
    Int J Cardiol. 2024 Mar 19:131968. doi: 10.1016/j.ijcard.2024.131968.
    >> Share

  14. BICHUETTE LD, Lottenberg MP, Caramelli B
    Hypertrophic cardiomyopathy as a high-risk feature on perioperative care: How to deal with this self-fulfilling prophecy?
    Int J Cardiol. 2024;399:131683.
    >> Share

  15. ZACH DK, Schwegel N, Santner V, Winkelbauer L, et al
    Low-grade systemic inflammation and left ventricular dysfunction in hypertensive compared to non-hypertensive hypertrophic cardiomyopathy.
    Int J Cardiol. 2024;399:131661.
    >> Share

  16. NASCIMENTO BR, Nunes MCP, da Silva JLP, Steer A, et al
    Outcomes of latent rheumatic heart disease: External validation of a simplified score in patients with and without secondary prophylaxis.
    Int J Cardiol. 2024;399:131662.
    >> Share

  17. FENG D, Zhao J, Niu G, Zhang Y, et al
    Outcomes for patients undergoing transcatheter aortic valve replacement with ascending aorta dilation.
    Int J Cardiol. 2024 Mar 11:131948. doi: 10.1016/j.ijcard.2024.131948.
    >> Share

  18. BONELLO B, Issitt R, Hughes M, Carr M, et al
    Long-term outcome after neonatal intervention for congenital critical aortic stenosis.
    Int J Cardiol. 2024 Mar 2:131932. doi: 10.1016/j.ijcard.2024.131932.
    >> Share

  19. BARSSOUM K, Abumoawad A, Chowdhury M, Agrawal A, et al
    Perioperative outcomes of hypertrophic cardiomyopathy: An insight from the National Readmission Database.
    Int J Cardiol. 2024;398:131601.
    >> Share

  20. LIU Z, Wei P, Jiang H, Zhang F, et al
    Corrigendum to 'Alerting trends in epidemiology for non-rheumatic degenerative mitral valve disease, 1990-2019: An age-period-cohort analysis for the Global Burden of Disease Study 2019' [Int. J. Cardiol. 395(2024) 131561].
    Int J Cardiol. 2024 Mar 1:131919. doi: 10.1016/j.ijcard.2024.131919.
    >> Share

    February 2024
  21. BOURG C, Lee KC, Donal E
    Understanding myocardial mechanics in primary mitral regurgitation: A contemporary approach.
    Int J Cardiol. 2024 Feb 17:131882. doi: 10.1016/j.ijcard.2024.131882.
    >> Share

  22. DI MAURO M, Guarracini S, Mazzocchetti L, Capuzzi D, et al
    Transcatheter bicaval valve system for the treatment of severe isolated tricuspid regurgitation. Features from a single-Centre experience.
    Int J Cardiol. 2024 Feb 16:131864. doi: 10.1016/j.ijcard.2024.131864.
    >> Share

  23. AKHTAR KH, Pahuja M, Baber U
    Self-expanding or balloon-expandable valve for TAVR in low risk patients: The jury is still out!
    Int J Cardiol. 2024;397:131619.
    >> Share

  24. DE MARZO V, Zimarino M
    The value of transaxillary access for TAVI.
    Int J Cardiol. 2024;397:131448.
    >> Share

  25. FATIMA K, Uddin QS, Tharwani ZH, Kashif MAB, et al
    Concomitant transthyretin cardiac amyloidosis in patients undergoing TAVR for aortic stenosis: A systemic review and meta-analysis.
    Int J Cardiol. 2024 Feb 15:131854. doi: 10.1016/j.ijcard.2024.131854.
    >> Share

  26. DANDEL M
    It is time to think about further optimization of the echocardiographic assessment of left ventricular responses to mitral regurgitation.
    Int J Cardiol. 2024 Feb 9:131841. doi: 10.1016/j.ijcard.2024.131841.
    >> Share

  27. KWAK S, Lee HJ, Lee H, Park JB, et al
    Age-dependent association of metabolic dyslipidemia with clinical expression of hypertrophic cardiomyopathy.
    Int J Cardiol. 2024;396:131574.
    >> Share

    January 2024
  28. KURASAWA S, Imaizumi T, Kondo T, Hishida M, et al
    Relationship between peak aortic jet velocity and progression of aortic stenosis in patients undergoing hemodialysis.
    Int J Cardiol. 2024 Jan 30:131822. doi: 10.1016/j.ijcard.2024.131822.
    >> Share

  29. ELKOUMY A, Ruck A, Abdel-Wahab M, Thiele H, et al
    ACURATE neo2 Transcatheter aortic valve implantation without balloon aortic valvuloplasty - direct ACURATE neo2.
    Int J Cardiol. 2024 Jan 19:131792. doi: 10.1016/j.ijcard.2024.131792.
    >> Share

  30. MUSUMECI B, Tini G, Biagini E, Merlo M, et al
    Clinical characteristics and outcome of end stage hypertrophic cardiomyopathy: Role of age and heart failure phenotypes.
    Int J Cardiol. 2024 Jan 18:131784. doi: 10.1016/j.ijcard.2024.131784.
    >> Share

  31. CARABETTA N, Siller-Matula JM, Boccuto F, Panuccio G, et al
    Commissural alignment during TAVR reduces the risk of overlap to coronary ostia.
    Int J Cardiol. 2024;395:131572.
    >> Share

  32. PARATZ ED, Stub D, Sutherland N, Gutman S, et al
    The challenge of risk stratification in hypertrophic cardiomyopathy: Clinical, genetic and imaging insights from a quaternary referral centre.
    Int J Cardiol. 2024;395:131416.
    >> Share

  33. DEL FRANCO A, Biagioni G, Mazzoni C, Cappelli F, et al
    Amyloidosis in spinal stenosis: How, when and whether cardiac screening has a clinical impact.
    Int J Cardiol. 2024;395:131413.
    >> Share

  34. SRAYA R, Amsalem I, Carasso S, Gilad O, et al
    Mitral valve gradient changes associate with outcomes of patients undergoing transcatheter edge-to-edge repair.
    Int J Cardiol. 2024 Jan 9:131766. doi: 10.1016/j.ijcard.2024.131766.
    >> Share

  35. PASTORE MC, Vannuccini F, Mandoli GE, Lisi M, et al
    Myocardial work and left heart deformation parameters across primary mitral regurgitation severity.
    Int J Cardiol. 2024 Jan 9:131772. doi: 10.1016/j.ijcard.2024.131772.
    >> Share

  36. LERMAN TT, Levi A, Kornowski R
    Response to: "Evolut R and Evolut PRO vs. Sapien 3 for transcatheter aortic valve implantation - The 'generation gap' and beyond".
    Int J Cardiol. 2024 Jan 5:131751. doi: 10.1016/j.ijcard.2024.131751.
    >> Share

  37. VAN WELY M, van Nieuwkerk AC, Rooijakkers M, van der Wulp K, et al
    Transaxillary versus transfemoral access as default access in TAVI: A propensity matched analysis.
    Int J Cardiol. 2024;394:131353.
    >> Share

    December 2023
  38. MOSCARELLA E, Ielasi A, Montonati C, Pellegrini D, et al
    Comparing two-year outcomes of balloon-expandable Myval and self-expanding Evolut R in severe aortic valve stenosis.
    Int J Cardiol. 2023 Dec 31:131701. doi: 10.1016/j.ijcard.2023.131701.
    >> Share

  39. ANWER S, Nussbaum S, Winkler NE, Benz DC, et al
    Left ventricular global work index and prediction of cardiovascular mortality after transcatheter aortic valve implantation.
    Int J Cardiol. 2023 Dec 29:131660. doi: 10.1016/j.ijcard.2023.131660.
    >> Share

  40. HIRAM R
    The duration of atrial fibrillation might be associated with right heart disease severity.
    Int J Cardiol. 2023 Dec 28:131689. doi: 10.1016/j.ijcard.2023.131689.
    >> Share

  41. ANTIA A, Pius R, Ndukauba C, Zarauz VR, et al
    Temporal trends in the utilization and outcome of transcatheter aortic valve replacement across racial and ethnic groups. A nationwide analysis.
    Int J Cardiol. 2023 Dec 22:131669. doi: 10.1016/j.ijcard.2023.131669.
    >> Share

  42. CAETANO L DA SILVA, Gibicoski TB, Rodriguez F, Scabello I, et al
    Impact of carotid artery stenosis on outcomes of transcatheter aortic valve replacement: A systematic review and meta-analysis.
    Int J Cardiol. 2023 Dec 22:131670. doi: 10.1016/j.ijcard.2023.131670.
    >> Share

  43. ADAMO M, Pagnesi M, Di Pasquale M, Ravera A, et al
    Differential biomarker expression in heart failure patients with and without mitral regurgitation: Insights from BIOSTAT-CHF.
    Int J Cardiol. 2023 Dec 21:131664. doi: 10.1016/j.ijcard.2023.131664.
    >> Share

  44. IZUMI K, Utsunomiya H, Takeuchi M, Hamada A, et al
    Relationship between duration of atrial fibrillation and right heart structure remodeling as assessed by 3-dimensional transesophageal echocardiography.
    Int J Cardiol. 2023 Dec 21:131667. doi: 10.1016/j.ijcard.2023.131667.
    >> Share

  45. BOLETI OD, Roussos S, Norrish G, Field E, et al
    Sudden cardiac death in childhood RASopathy-associated hypertrophic cardiomyopathy: Validation of the HCM risk-kids model and predictors of events.
    Int J Cardiol. 2023;393:131405.
    >> Share

  46. OZLEK B
    Tricuspid regurgitation and heart failure with preserved ejection fraction: An enigma in cardiology practice.
    Int J Cardiol. 2023 Dec 10:131649. doi: 10.1016/j.ijcard.2023.131649.
    >> Share

  47. GOZDEK M, Kowalewski M
    Evolut R and Evolut PRO vs. Sapien 3 for transcatheter aortic valve implantation - The 'generation gap' and beyond.
    Int J Cardiol. 2023 Dec 8:131647. doi: 10.1016/j.ijcard.2023.131647.
    >> Share

  48. SEE C, Wang Y, Yang Y, Tirziu D, et al
    Impact of sex on transcatheter aortic valve replacement outcomes: Results of a single-center study.
    Int J Cardiol. 2023 Dec 6:131643. doi: 10.1016/j.ijcard.2023.131643.
    >> Share

  49. HOLIEROOK M, Henstra MJ, Dolman DJ, Chekanova EV, et al
    Higher Edmonton Frail Scale prior to transcatheter Aortic Valve Implantation is related to longer hospital stay and mortality.
    Int J Cardiol. 2023 Dec 6:131637. doi: 10.1016/j.ijcard.2023.131637.
    >> Share

  50. MATTIG I, Steudel T, Barzen G, Frumkin D, et al
    Diagnostic value of papillary muscle hypertrophy and mitral valve thickness to discriminate cardiac amyloidosis and Fabry disease.
    Int J Cardiol. 2023 Dec 3:131629. doi: 10.1016/j.ijcard.2023.131629.
    >> Share

    November 2023
  51. FERNANDEZ-GOLFIN C, Gonznalez-Gomez A
    Unmasking tricuspid regurgitation.
    Int J Cardiol. 2023 Nov 28:131609. doi: 10.1016/j.ijcard.2023.131609.
    >> Share

  52. KIKUCHI S, Minamimoto Y, Matsushita K, Cho T, et al
    Ratio of left ventricular outflow tract area to aortic annulus area and complete atrioventricular block after transcatheter aortic valve replacement for aortic stenosis.
    Int J Cardiol. 2023 Nov 27:131608. doi: 10.1016/j.ijcard.2023.131608.
    >> Share

  53. CHAN J, Narayan P, Fudulu DP, Dong T, et al
    Trend in mitral valve prostheses of choice and early outcomes in the United Kingdom.
    Int J Cardiol. 2023 Nov 25:131607. doi: 10.1016/j.ijcard.2023.131607.
    >> Share

  54. HAUGE SW, Estensen ME, Persson R, Abebe S, et al
    The importance of concomitant mitral regurgitation for estimates of mitral valve area by pressure half time in patients with chronic rheumatic heart disease.
    Int J Cardiol. 2023 Nov 21:131600. doi: 10.1016/j.ijcard.2023.131600.
    >> Share

  55. MOSCARELLI M, Sollami G, Lentini E, Prestera R, et al
    About different localization of hypoattenuated lesions following transcatheter aortic valve replacement.
    Int J Cardiol. 2023 Nov 16:131597. doi: 10.1016/j.ijcard.2023.131597.
    >> Share

  56. HU D, Lan T, Chen Y, Chen L, et al
    An 18-year evolution of congenital heart disease in China: An echocardiographic database-based study.
    Int J Cardiol. 2023;391:131286.
    >> Share

  57. KHOURY S, Bhatia RT, Marwaha S, Miles C, et al
    Ethnic and sex-related differences at presentation in apical hypertrophic cardiomyopathy: An observational cross-sectional study.
    Int J Cardiol. 2023;391:131265.
    >> Share

  58. WU Z, Nie C, Zhu C, Meng Y, et al
    Mitral annular calcification in obstructive hypertrophic cardiomyopathy: Incidence, risk factors, and prognostic value after myectomy.
    Int J Cardiol. 2023;391:131266.
    >> Share

  59. DE SARRO R, Sabatino J
    Left atrial function's evaluation in aortic stenosis: A clinical imperative.
    Int J Cardiol. 2023 Nov 11:131579. doi: 10.1016/j.ijcard.2023.131579.
    >> Share

  60. LOSI MA, Monda E, Lombardi R, Lioncino M, et al
    Prediction of incident atrial fibrillation in hypertrophic cardiomyopathy.
    Int J Cardiol. 2023 Nov 9:131575. doi: 10.1016/j.ijcard.2023.131575.
    >> Share

  61. ZHOU N, Liu A, Weng H, Liu W, et al
    Three-dimensional echocardiography reveals early mitral valve alterations in hypertrophic cardiomyopathy genetic mutation carriers.
    Int J Cardiol. 2023 Nov 8:131576. doi: 10.1016/j.ijcard.2023.131576.
    >> Share

  62. DORES H, Toste A, Cardim N
    Hypertrophic cardiomyopathy in patients with a normal electrocardiogram: A view from the east side of the Atlantic Ocean.
    Int J Cardiol. 2023;390:131260.
    >> Share

  63. SALA A, Alfieri O
    Surgical ablation in hypertrophic obstructive cardiomyopathy: What is the real deal?
    Int J Cardiol. 2023;390:131146.
    >> Share

  64. NEMES A
    Three-dimensional echocardiography for Tricuspid Annulus - Transthoracic or transoesophageal approach?
    Int J Cardiol. 2023;390:131170.
    >> Share

    October 2023
  65. BRANDES A
    Rheumatic mitral valve stenosis and atrial fibrillation - Vicious twins.
    Int J Cardiol. 2023 Oct 30:131566. doi: 10.1016/j.ijcard.2023.131566.
    >> Share

  66. LIU Z, Wei P, Jiang H, Zhang F, et al
    Alerting trends in epidemiology for non-rheumatic degenerative mitral valve disease, 1990-2019: An age-period-cohort analysis for the Global Burden of Disease Study 2019.
    Int J Cardiol. 2023 Oct 30:131561. doi: 10.1016/j.ijcard.2023.131561.
    >> Share

  67. MOSCARELLI M, Prestera R, Fiore C, Pernice V, et al
    Evaluation of the anatomic sinus after transcatheter aortic valve replacement.
    Int J Cardiol. 2023 Oct 20:131551. doi: 10.1016/j.ijcard.2023.131551.
    >> Share

  68. HOU Q, Wu W, Fang L, Zhang X, et al
    Patient-specific computational fluid dynamics for hypertrophic obstructive cardiomyopathy.
    Int J Cardiol. 2023;389:131263.
    >> Share

  69. BADWAN O, Mirzai S, Skoza W, Hawk F, et al
    Clinical outcomes following tricuspid transcatheter edge-to-edge repair with PASCAL: A meta-analysis.
    Int J Cardiol. 2023;389:131194.
    >> Share

  70. LEONARDI D, Bursi F, Fanti D, Dotto A, et al
    Outpatient tricuspid regurgitation in the community: Clinical context and outcome.
    Int J Cardiol. 2023 Oct 14:131443. doi: 10.1016/j.ijcard.2023.131443.
    >> Share

  71. BHOGAL S, Waksman R, Shea C, Zhang C, et al
    Self-expanding and balloon-expandable valves in low risk TAVR patients.
    Int J Cardiol. 2023 Oct 12:131431. doi: 10.1016/j.ijcard.2023.131431.
    >> Share

  72. MYAGMARDORJ R, Stassen J, Nabeta T, Hirasawa K, et al
    Impact of chronic obstructive pulmonary disease on right ventricular function and remodeling after aortic valve replacement.
    Int J Cardiol. 2023 Oct 5:131414. doi: 10.1016/j.ijcard.2023.131414.
    >> Share

  73. CHEN X
    The real world of stroke incidence in patients with hypertrophic cardiomyopathy.
    Int J Cardiol. 2023;388:131172.
    >> Share

  74. MARTIN M, Moris C
    Subclinical leaflet thrombosis after TAVI: To be or not to be.
    Int J Cardiol. 2023;388:131140.
    >> Share

    September 2023
  75. YAMANO M, Yamano T, Nakamura T, Zukeran T, et al
    Mitral regurgitation outcomes after transcatheter atrial septal defect closure.
    Int J Cardiol. 2023 Sep 28:131404. doi: 10.1016/j.ijcard.2023.131404.
    >> Share

  76. WINKLER NE, Anwer S, Rumpf PM, Tsiourantani G, et al
    Left atrial pump strain predicts long-term survival after transcatheter aortic valve implantation.
    Int J Cardiol. 2023 Sep 28:131403. doi: 10.1016/j.ijcard.2023.131403.
    >> Share

  77. CHANG WT, Lin CH, Lee WC, Kan WC, et al
    Signal intensity coefficient as a detector of aortic stenosis-induced myocardial fibrosis and its correlation to the long term outcome.
    Int J Cardiol. 2023 Sep 17:131367. doi: 10.1016/j.ijcard.2023.131367.
    >> Share

  78. KHARBANDA RK, Ramdat Misier NL, Van den Eynde J, El Mathari S, et al
    Outcomes of concomitant surgical ablation in patients undergoing surgical myectomy for hypertrophic obstructive cardiomyopathy: A systematic review and meta-analysis.
    Int J Cardiol. 2023;387:131099.
    >> Share

  79. SOARES JR, Carvalho VT, Lodi-Junqueira L, Fonseca IMG, et al
    Assessment of the left atrial volume and function following percutaneous mitral balloon valvuloplasty: Insights into acute and late impact of atrial fibrillation on atrial remodeling.
    Int J Cardiol. 2023 Sep 12:131361. doi: 10.1016/j.ijcard.2023.131361.
    >> Share

  80. LEOW R, Kong WKF, Li TY, Poh KK, et al
    Yeo's index: A novel index that combines anatomic and haemodynamic assessment of the severity of mitral stenosis.
    Int J Cardiol. 2023 Sep 7:131350. doi: 10.1016/j.ijcard.2023.131350.
    >> Share

  81. HASEGAWA H, Kuwajima K, Kagawa S, Yamane T, et al
    Impact of eccentric jet on outcomes in patients with atrial functional mitral regurgitation: An echocardiographic study.
    Int J Cardiol. 2023 Sep 5:131342. doi: 10.1016/j.ijcard.2023.131342.
    >> Share

  82. YAMAZAKI C, Higuchi R, Saji M, Takamisawa I, et al
    Discrepancy between invasive and echocardiographic transvalvular gradient after TAVI: Insights from the LAPLACE-TAVI registry.
    Int J Cardiol. 2023;386:17-23.
    >> Share

    August 2023
  83. GENTILE F, Buoncristiani F, Sciarrone P, Bazan L, et al
    Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation.
    Int J Cardiol. 2023 Aug 19:131272. doi: 10.1016/j.ijcard.2023.131272.
    >> Share

  84. LI S, Fang L, Wu W, Zhang Z, et al
    Echocardiographic diagnosis of rupture of mitral valve papillary muscle.
    Int J Cardiol. 2023 Aug 18:131273. doi: 10.1016/j.ijcard.2023.131273.
    >> Share

  85. PIERONI M, Ciabatti M, Bolognese L
    Stroke in hypertrophic cardiomyopathy. Never mind the rhythm.
    Int J Cardiol. 2023;385:41-42.
    >> Share

  86. NEMES A
    The tricuspid annulus in repaired tetralogy of Fallot - what does it play and what does it not?
    Int J Cardiol. 2023;385:22.
    >> Share

    July 2023
  87. SISINNI A, Estevez-Loureiro R
    The K-clip: Time for a new tricuspid valve focal annuloplasty system.
    Int J Cardiol. 2023 Jul 31:131234. doi: 10.1016/j.ijcard.2023.131234.
    >> Share

  88. BARKI M, Ielasi A, Buono A, Maffeo D, et al
    Transcatheter aortic valve replacement with the self-expanding ACURATE Neo2 in patients with horizontal aorta: Insights from the ITAL-neo registry.
    Int J Cardiol. 2023 Jul 31:131236. doi: 10.1016/j.ijcard.2023.131236.
    >> Share

  89. SANCHIS L, Farrero M
    Edge to edge mitral valve repair beyond COAPT criteria: A bridge to further therapies for patients with advanced heart failure.
    Int J Cardiol. 2023 Jul 31:131235. doi: 10.1016/j.ijcard.2023.131235.
    >> Share

  90. MIRZAI S, Aleixo GFP, Mazumder S, Berglund F, et al
    Sarcopenia evaluation on cardiac magnetic resonance imaging in older adults for outcomes prediction following surgical aortic valve replacement.
    Int J Cardiol. 2023 Jul 25:131216. doi: 10.1016/j.ijcard.2023.131216.
    >> Share

  91. BHOGAL S, Rogers T, Merdler I, Reddy P, et al
    Evolut PRO/PRO+ versus Evolut R system for transcatheter aortic valve replacement.
    Int J Cardiol. 2023 Jul 19:131196. doi: 10.1016/j.ijcard.2023.131196.
    >> Share

  92. ZHANG X, Jin Q, Pan W, Li W, et al
    First-in-human study of the K-Clip transcatheter annular repair system for severe functional tricuspid regurgitation.
    Int J Cardiol. 2023 Jul 11:131174. doi: 10.1016/j.ijcard.2023.131174.
    >> Share

  93. CHATTERJEE A, Kazui T, Acharya D
    Growing prevalence of aortic stenosis - Question of age or better recognition?
    Int J Cardiol. 2023 Jul 8:131155. doi: 10.1016/j.ijcard.2023.131155.
    >> Share

  94. XU Z, Dai XF, Lin F, Chen LW, et al
    Two-incision totally thoracoscopic mitral valve repair combined with radiofrequency atrial fibrillation ablation in rheumatic mitral valve disease: Early results of a case series of 43 consecutive patients.
    Int J Cardiol. 2023 Jul 8:131158. doi: 10.1016/j.ijcard.2023.131158.
    >> Share

  95. MASSERA D, Sherrid MV, Maron MS, Rowin EJ, et al
    How common is hypertrophic cardiomyopathy... really?: Disease prevalence revisited 27 years after CARDIA.
    Int J Cardiol. 2023;382:64-67.
    >> Share

  96. SA MP, Tasoudis P, Jacquemyn X, Van den Eynde J, et al
    Long-term outcomes of valve-sparing root versus composite valve graft replacement for acute type A aortic dissection: Meta-analysis of reconstructed time-to-event data.
    Int J Cardiol. 2023;382:12-19.
    >> Share

    June 2023
  97. MARGONATO D, Ancona F, Cesari A, Ghantous E, et al
    The long-term clinical course of moderate tricuspid regurgitation.
    Int J Cardiol. 2023 Jun 24:131135. doi: 10.1016/j.ijcard.2023.131135.
    >> Share

  98. LIND A, Esfahan MA, Totzeck M, Al-Rashid F, et al
    Virtual reality-assisted distraction during transcatheter aortic valve implantation under local anaesthesia: A randomised study.
    Int J Cardiol. 2023 Jun 22:131130. doi: 10.1016/j.ijcard.2023.131130.
    >> Share

  99. MUNAFO AR, Scotti A, Estevez-Loureiro R, Adamo M, et al
    2-year outcomes of MitraClip as a bridge to heart transplantation: The international MitraBridge registry.
    Int J Cardiol. 2023 Jun 22:131139. doi: 10.1016/j.ijcard.2023.131139.
    >> Share

  100. LEE M, Shechter A, Han D, Nguyen LC, et al
    Left ventricular morphologic progression in apical hypertrophic cardiomyopathy.
    Int J Cardiol. 2023;381:62-69.
    >> Share

  101. BOURG C, Curtis E, Donal E
    Navigating upstream and downstream: Unleashing the prognostic potential of RVFWLS/PASP ratio in severe tricuspid regurgitation.
    Int J Cardiol. 2023 Jun 12:S0167-5273(23)00881.
    >> Share

  102. RAHIMI M, Kpodonu J
    Myectomy or myomectomy, that is the question.
    Int J Cardiol. 2023;380:28.
    >> Share

  103. SCHEFFERS LE, Kok R, van den Berg LE, van den Hout JMP, et al
    Effects of enzyme replacement therapy on cardiac function in classic infantile Pompe disease.
    Int J Cardiol. 2023;380:65-71.
    >> Share

    May 2023
  104. FERSTL P, Achenbach S, Marwan M, Bittner DO, et al
    Comparison of oral anticoagulation by vitamin-K antagonists and non-vitamin-K antagonists for treatment of leaflet thickening after transcatheter aortic valve implantation (TAVI).
    Int J Cardiol. 2023 May 25:S0167-5273(23)00727.
    >> Share

  105. ZHOU Y, Lin X, Zhu Q, Li H, et al
    Association between trajectories in cardiac damage and clinical outcomes after transcatheter aortic valve replacement.
    Int J Cardiol. 2023 May 11:S0167-5273(23)00707.
    >> Share

  106. FRANCESCO A, Davide M, Gregorio M, Matteo B, et al
    Ratio between right ventricular longitudinal strain and pulmonary arterial systolic pressure: A novel prognostic parameter in patients with severe tricuspid regurgitation.
    Int J Cardiol. 2023 May 4:S0167-5273(23)00647.
    >> Share

  107. EGBE AC, Miranda WR, Anderson JH, Pellikka PA, et al
    Left ventricular adaptation to aortic regurgitation in adults with repaired coarctation of aorta.
    Int J Cardiol. 2023 May 4:S0167-5273(23)00650.
    >> Share

    April 2023
  108. AMBROSY AP, Go AS, Leong TK, Garcia EA, et al
    Temporal trends in the prevalence and severity of aortic stenosis within a contemporary and diverse community-based cohort.
    Int J Cardiol. 2023 Apr 27:S0167-5273(23)00601.
    >> Share

  109. SHOJI S, Kuno T, Malik A, Briasoulis A, et al
    Association between institutional volume of transcatheter mitral valve repair and readmission rates: A report from the National Readmission Database.
    Int J Cardiol. 2023 Apr 19:S0167-5273(23)00588.
    >> Share

  110. FUMAGALLI C, Bonanni F, Beltrami M, Ruggieri R, et al
    Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoring.
    Int J Cardiol. 2023 Apr 13:S0167-5273(23)00523.
    >> Share

  111. LEIBOWITZ D, Yoshida Y, Jin Z, Nakanishi K, et al
    Factors associated with the progression of aortic valve calcification in older adults.
    Int J Cardiol. 2023 Apr 6:S0167-5273(23)00470.
    >> Share

  112. ELKOUMY A, Jose J, Gunasekaran S, Kumar A, et al
    Angiographic quantification of aortic regurgitation following myval octacor implantation; independent core lab adjudication.
    Int J Cardiol. 2023 Apr 5:S0167-5273(23)00516.
    >> Share

  113. MERLO M, Folgheraiter A, Sinagra G
    Evolving mortality and clinical scenarios in HCM: Where are we?
    Int J Cardiol. 2023;376:97-99.
    >> Share

    March 2023
  114. MENG H, Zhao X, Wang JD, Wan LY, et al
    Comparison between multimodality imaging approaches for measurement of the tricuspid annulus in severe tricuspid regurgitation.
    Int J Cardiol. 2023 Mar 31:S0167-5273(23)00434.
    >> Share

  115. DE MARZO V, Viglino U, Zecchino S, Matos JG, et al
    Supra-renal aortic atheroma extent and composition predict acute kidney injury after transcatheter aortic valve replacement: A three-dimensional computed tomography study.
    Int J Cardiol. 2023 Mar 29:S0167-5273(23)00464.
    >> Share

  116. MENDEL B, Kohar K, Amirah S, Vidya AP, et al
    The outcomes of fetal aortic valvuloplasty in critical aortic stenosis: A systematic review and meta-analysis.
    Int J Cardiol. 2023 Mar 28:S0167-5273(23)00461.
    >> Share

  117. SAMBOLA A, Soriano-Colome T
    New insights into cardiovascular events in women after TAVI. Lessons from TAVI-WIN Registry.
    Int J Cardiol. 2023;375:21-22.
    >> Share

  118. ESPOSITO G, Montalto C, Crimi G, Grippo R, et al
    Time course of ischemic and bleeding burden in consecutive patients undergoing transcatheter aortic valve replacement (FOCUS-ONE registry).
    Int J Cardiol. 2023 Mar 8:S0167-5273(23)00336.
    >> Share

  119. ZAMPIERI M, Salvi S, Fumagalli C, Argiro A, et al
    Clinical scenarios of hypertrophic cardiomyopathy-related mortality: Relevance of age and stage of disease at presentation.
    Int J Cardiol. 2023;374:65-72.
    >> Share

    February 2023
  120. LEONE PP, Gohar A, Pagnesi M, Mangieri A, et al
    Clinical outcomes in women and men with small aortic annuli undergoing transcatheter aortic valve implantation: A multicenter, retrospective, propensity score-matched comparison.
    Int J Cardiol. 2023 Feb 28:S0167-5273(23)00270.
    >> Share

  121. MALTES S, Abecasis J, Santos RR, Lopes P, et al
    LGE prevalence and patterns in severe aortic stenosis: When "junctional" means the same.
    Int J Cardiol. 2023 Feb 22:S0167-5273(23)00250.
    >> Share

  122. GESKE JB, Siontis KC, Gersh BJ
    Syncope in hypertrophic cardiomyopathy: Explaining the unexplained.
    Int J Cardiol. 2023;373:99-100.
    >> Share

  123. D'ELIA N, Gall S, Potter E, Wright L, et al
    Echocardiographic detection of heart valve disease in a community cohort of asymptomatic Australians > 65 years with cardiovascular risk factors.
    Int J Cardiol. 2023;373:107-109.
    >> Share

  124. ZHAO X, Jin F, Wang J, Zhao X, et al
    Entropy of left ventricular late gadolinium enhancement and its prognostic value in hypertrophic cardiomyopathy a new CMR assessment method.
    Int J Cardiol. 2023;373:134-141.
    >> Share

  125. CONSTANTINE A, Dimopoulos K, Heng EL, Kempny A, et al
    Transcatheter pulmonary valve implantation: An option for the few becoming an option for the many.
    Int J Cardiol. 2023;373:44-46.
    >> Share

  126. YEERKEN M, Lu Y, Wang Q
    The potency of transthoracic echocardiography in assessing arrhythmogenic trigger and substrate: Novel risk markers for malignant mitral valve prolapse.
    Int J Cardiol. 2023 Feb 10:S0167-5273(23)00231.
    >> Share

  127. HAUM M, Humpfer F, Steffen J, Fischer J, et al
    Quantification of physical activity with prospective activity tracking after transfemoral aortic valve replacement.
    Int J Cardiol. 2023 Feb 7:S0167-5273(23)00168.
    >> Share

  128. BREEMAN KTN, Peijster AJL, De Bruin-Bon HACM, Pepplinkhuizen S, et al
    Worsening tricuspid regurgitation after ICD implantation is rather due to transvenous lead than natural progression.
    Int J Cardiol. 2023 Feb 7:S0167-5273(23)00183.
    >> Share

    January 2023
  129. CRANE AD, Saijo Y, Kocyigit D, Tharwani A, et al
    Severe mitral regurgitation in nonagenarians: Impact of symptomatic status, frailty and etiology on management and outcomes.
    Int J Cardiol. 2023 Jan 23:S0167-5273(23)00066.
    >> Share

  130. SRINIVASAN A, Brown J, Ahmed H, Daniel M, et al
    PASCAL repair system for patients with mitral regurgitation: A systematic review.
    Int J Cardiol. 2023 Jan 19:S0167-5273(23)00067.
    >> Share

  131. LIN F, Wang Q, Meng L, Liang Y, et al
    Cardiac computed tomography based analysis of mitral annulus, coronary sinus and left circumflex artery in patients with mitral regurgitation: Implications for transcatheter mitral annuloplasty techniques.
    Int J Cardiol. 2023 Jan 18:S0167-5273(23)00064.
    >> Share

  132. BHOGAL S, Waksman R, Gordon P, Ehsan A, et al
    Subclinical leaflet thrombosis and antithrombotic therapy post-TAVI: An LRT substudy.
    Int J Cardiol. 2023;371:305-311.
    >> Share

  133. WANG K, Zhou M, Zhang Y, Du Y, et al
    IRX2 activated by jumonji domain-containing protein 2A is crucial for cardiac hypertrophy and dysfunction in response to the hypertrophic stimuli.
    Int J Cardiol. 2023;371:332-344.
    >> Share

  134. THOMPSON SE, Prabhakar CRK, Creasey T, Stoll VM, et al
    Pregnancy outcomes in women following the Ross procedure.
    Int J Cardiol. 2023;371:135-139.
    >> Share

  135. TOPRICEANU CC, Field E, Boleti O, Cervi E, et al
    Disopyramide is a safe and effective treatment for children with obstructive hypertrophic cardiomyopathy.
    Int J Cardiol. 2023;371:523-525.
    >> Share

  136. PAGANO M, Fumagalli C, Girolami F, Passantino S, et al
    Clinical profile and outcome of cardiomyopathies in infants and children seen at a tertiary centre.
    Int J Cardiol. 2023;371:516-522.
    >> Share

  137. STEFANO P, Argiro A, Bacchi B, Iannone L, et al
    Does a standard myectomy exist for obstructive hypertrophic cardiomyopathy? From the Morrow variations to precision surgery.
    Int J Cardiol. 2023;371:278-286.
    >> Share

  138. DZIEWIERZ A
    The time is always right to do what is right: TAVI and timing of PCI.
    Int J Cardiol. 2023;371:128-129.
    >> Share

  139. YANG K, Yu SQ, Chen XY, Song YY, et al
    Apical aneurysm formation in apical hypertrophic cardiomyopathy: Pilot study with cardiac magnetic resonance.
    Int J Cardiol. 2023;371:480-485.
    >> Share

  140. DE BRITO FS JR, Sarmento-Leite R, Dangas G
    The ongoing dilemma of anticoagulation after TAVI: Seek quality evidence.
    Int J Cardiol. 2023;371:329-330.
    >> Share

  141. MORAL S, Abuli M, Mendez I, Gonzalez-Gomez A, et al
    Invasive management of significant tricuspid regurgitation in clinical practice.
    Int J Cardiol. 2023 Jan 12:S0167-5273(23)00048.
    >> Share

  142. FELDT K, Dalen M, Meduri CU, Kastengren M, et al
    Reducing cardiac tamponade caused by temporary pacemaker perforation in transcatheter aortic valve replacement.
    Int J Cardiol. 2023 Jan 11:S0167-5273(23)00047.
    >> Share

  143. ESTEVEZ-LOUREIRO R, Barreiro-Perez M
    Transcatheter tricuspid valve replacement: Beyond symptom improvement.
    Int J Cardiol. 2023 Jan 5:S0167-5273(22)01978.
    >> Share

  144. KIM WK, Abdel-Wahab M
    Higher short-term mortality of Evolut versus Sapien 3: A piece of the puzzle?
    Int J Cardiol. 2023;370:351-352.
    >> Share

  145. BONAVENTURA J
    Rediscovering therapies for hypertrophic cardiomyopathy.
    Int J Cardiol. 2023;370:319-320.
    >> Share

  146. QIN L, Zhu S, Liu P, Zhu L, et al
    Additional prognostic values of strain and strain rate over late gadolinium enhancement in hypertrophic cardiomyopathy patients.
    Int J Cardiol. 2023;370:427-434.
    >> Share

  147. BRIGNOLE M, Cecchi F, Anastasakis A, Crotti L, et al
    Syncope in hypertrophic cardiomyopathy (part II): An expert consensus statement on the diagnosis and management.
    Int J Cardiol. 2023;370:330-337.
    >> Share

  148. BARBOSA MC, Cirillo W, Piza F, Figueiredo MJO, et al
    Determinants and prognostic value of in-hospital infection in patients waiting for permanent pacemaker implantation.
    Int J Cardiol. 2023;370:204-208.
    >> Share

  149. HOUEIJEH A, Batteux C, Karsenty C, Ramdane N, et al
    Long-term outcomes of transcatheter pulmonary valve implantation with melody and SAPIEN valves.
    Int J Cardiol. 2023;370:156-166.
    >> Share

  150. ARGIRO A, Zampieri M, Dei LL, Ferrantini C, et al
    Safety and efficacy of ranolazine in hypertrophic cardiomyopathy: Real-world experience in a National Referral Center.
    Int J Cardiol. 2023;370:271-278.
    >> Share

  151. KIM EK, Hwang JW, Chang SA, Park SJ, et al
    Different characteristics of apical aneurysm in hypertrophic cardiomyopathy are related to difference in long-term prognosis.
    Int J Cardiol. 2023;370:287-293.
    >> Share

    December 2022
  152. STANKOVIC I, Dweck MR
    Global strain in moderate aortic valve stenosis with reduced left ventricular ejection fraction: A piece of the puzzle.
    Int J Cardiol. 2022 Dec 31:S0167-5273(22)01975.
    >> Share

  153. KO E, Park DW
    Conduction disturbances after TAVR with newer-generation self-expanding valves.
    Int J Cardiol. 2022;369:45-46.
    >> Share

  154. PELLICCIA A
    New evidences recommend an active lifestyle in young HCM patients.
    Int J Cardiol. 2022;369:82-83.
    >> Share

  155. YEERKEN M, Wen Y, Lv H, Tang B, et al
    Arrhythmic mitral annular disjunction syndrome: An underestimated cause of sudden cardiac death.
    Int J Cardiol. 2022;369:19-20.
    >> Share

  156. LERTSANGUANSINCHAI P, Chokesuwattanaskul R, Petchlorlian A, Suttirut P, et al
    Machine learning-based predictive risk models for 30-day and 1-year mortality in severe aortic stenosis patients undergoing transcatheter aortic valve implantation.
    Int J Cardiol. 2022 Dec 15:S0167-5273(22)01897.
    >> Share

  157. DREYFUS J, Messika-Zeitoun D
    Cardiac implantable electronic devices: Leads can lead to tricuspid regurgitation and death!
    Int J Cardiol. 2022 Dec 7:S0167-5273(22)01884.
    >> Share

  158. LV H, Fan Y, Yeerken M, Gao L, et al
    Radiofrequency ablation of hypertrophic obstructive cardiomyopathy - a potential method for clinical application.
    Int J Cardiol. 2022;368:53-54.
    >> Share

    November 2022
  159. VAN BERGEIJK KH, Wykrzykowska JJ, Sartori S, Snyder C, et al
    Pre-procedural oral anticoagulant use is associated with cardiovascular events in women after transcatheter aortic valve replacement: An analysis from the WIN-TAVI cohort.
    Int J Cardiol. 2022 Nov 28:S0167-5273(22)01743.
    >> Share

  160. LEE H, Kim J, Jung JH, Yoo JS, et al
    Surgical edge-to-edge repair for tricuspid regurgitation: Impact of the concomitant annuloplasty.
    Int J Cardiol. 2022 Nov 28:S0167-5273(22)01742.
    >> Share

  161. NING X, Cao J, Wang W, Xu Z, et al
    Impact of transcatheter tricuspid valve replacement for tricuspid regurgitation on hepatic, cardiac, and venous structure.
    Int J Cardiol. 2022 Nov 27:S0167-5273(22)01744.
    >> Share

  162. OFFEN SM, Puranik R, Baker D, Cordina R, et al
    Prevalence and determinants of tricuspid regurgitation after repair of tetralogy of Fallot.
    Int J Cardiol. 2022 Nov 24:S0167-5273(22)01726.
    >> Share

  163. STASSEN J, Singh GK, Pio SM, Chimed S, et al
    Incremental value of left ventricular global longitudinal strain in moderate aortic stenosis and reduced left ventricular ejection fraction.
    Int J Cardiol. 2022 Nov 22:S0167-5273(22)01722.
    >> Share

  164. SA MP, Van den Eynde J, Simonato M, Hirji S, et al
    Late outcomes of valve-in-valve transcatheter aortic valve implantation versus re-replacement: Meta-analysis of reconstructed time-to-event data.
    Int J Cardiol. 2022 Nov 10. pii: S0167-5273(22)01699.
    >> Share

  165. XU B, Khayata M
    Isolated tricuspid valve surgery: The devil is infective endocarditis?
    Int J Cardiol. 2022 Nov 2. pii: S0167-5273(22)01675.
    >> Share

  166. SALMASI MY, Morris-Rosendahl D, Jarral OA, Rosendahl U, et al
    Determining the genetic contribution in patients with non-syndromic ascending thoracic aortic aneurysms: Correlation with findings from computational pathology.
    Int J Cardiol. 2022;366:1-9.
    >> Share

  167. FRANCIA P, Silvetti G, Cosentino P, Cristiano E, et al
    Relation of delayed intrinsicoid deflection of the QRS complex to sudden cardiac death in patients with hypertrophic cardiomyopathy.
    Int J Cardiol. 2022;366:42-47.
    >> Share

    October 2022
  168. OFFEN S, Strange G, Playford D, Celermajer DS, et al
    Prevalence and prognostic impact of tricuspid regurgitation in patients with cardiac implantable electronic devices: From the national echocardiography database of Australia.
    Int J Cardiol. 2022 Oct 29. pii: S0167-5273(22)01671.
    >> Share

  169. STEFFEN J, Andreae D, Nabauer M, Reissig N, et al
    TAVI for patients with normal-flow low-gradient compared to high-gradient aortic stenosis.
    Int J Cardiol. 2022 Oct 25. pii: S0167-5273(22)01655.
    >> Share

  170. PAN L, Deng Y, Dai S, Feng X, et al
    Development and internal validation of a prediction model for acute kidney injury following cardiac valve replacement surgery.
    Int J Cardiol. 2022 Oct 25. pii: S0167-5273(22)01657.
    >> Share

  171. ALI LA, Marrone C, Martins DS, Khraiche D, et al
    Prognostic factors in hypertrophic cardiomyopathy in children: An MRI based study.
    Int J Cardiol. 2022;364:141-147.
    >> Share

  172. ANDREASSEN K, Dejgaard LA, Lie O, Fink TS, et al
    Exercise training during childhood and adolescence is associated with favorable diastolic function in hypertrophic cardiomyopathy.
    Int J Cardiol. 2022;364:65-71.
    >> Share

  173. SCOTTI A, Sturla M, Coisne A, Assafin M, et al
    Monitoring conduction disturbances following TAVR: Feasibility study of early discharge using a novel telemetry patch.
    Int J Cardiol. 2022;364:35-37.
    >> Share

  174. MUSICANTE M, Kim HH, Chen Y, Liao F, et al
    Regulation of endothelial nitric oxide synthase in cardiac remodeling.
    Int J Cardiol. 2022;364:96-101.
    >> Share

    September 2022
  175. LERMAN TT, Levi A, Kornowski R
    Meta-analysis of short- and long-term clinical outcomes of the self-expanding Evolut R/pro valve versus the balloon-expandable Sapien 3 valve for transcatheter aortic valve implantation.
    Int J Cardiol. 2022 Sep 18. pii: S0167-5273(22)01385.
    >> Share

  176. GESKE JB, Gersh BJ
    Explaining unexplained syncope in hypertrophic cardiomyopathy: A clinical dilemma.
    Int J Cardiol. 2022;363:125-126.
    >> Share

  177. HIGUCHI S, Orban M, Adamo M, Giannini C, et al
    Sex-specific impact of anthropometric parameters on outcomes after transcatheter edge-to-edge repair for secondary mitral regurgitation.
    Int J Cardiol. 2022 Sep 14. pii: S0167-5273(22)01337.
    >> Share

  178. DI MAURO M, Russo M, Saitto G, Lio A, et al
    Prognostic role of endocarditis in isolated tricuspid valve surgery. A propensity-weighted study.
    Int J Cardiol. 2022 Sep 13. pii: S0167-5273(22)01330.
    >> Share

  179. FANG M, Li B, Li X, Wang Y, et al
    MicroRNA-29b regulates pyroptosis involving calcific aortic valve disease through the STAT3/SOCS1 pathway.
    Int J Cardiol. 2022 Sep 2. pii: S0167-5273(22)01196.
    >> Share

  180. LILLO R, Graziani F
    Pregnancy in hypertrophic cardiomyopathy: New data, old questions.
    Int J Cardiol. 2022;362:126-127.
    >> Share

  181. SHINTANI Y, Nakayama T, Masaki A, Yokoi M, et al
    Clinical impact of the pathological quantification of myocardial fibrosis and infiltrating T lymphocytes using an endomyocardial biopsy in patients with hypertrophic cardiomyopathy.
    Int J Cardiol. 2022;362:110-117.
    >> Share

  182. OJEDA S, Pan M
    Aortic annuli in transcatheter valve implantation: "The bigger is not the better".
    Int J Cardiol. 2022;362:57-58.
    >> Share

    August 2022
  183. NEDIOS S, Steven D, Sultan A
    Atrioventricular coupling in hypertrophic cardiomyopathy: Partners in crime for new-onset atrial fibrillation.
    Int J Cardiol. 2022 Aug 18. pii: S0167-5273(22)01195.
    >> Share

  184. AMAT-SANTOS IJ, Blasco-Turrion S, Avanzas P
    Micro-dislodgement of Acurate neo 2 transcatheter heart valve: The right shoe for Cinderella.
    Int J Cardiol. 2022;361:29-30.
    >> Share

  185. GALLO F, Gallone G, Kim WK, Reifart J, et al
    Procedural outcomes of the 34 mm EvolutR Transcatheter valve in a real-world population insights from the HORSE multicenter collaborative registry.
    Int J Cardiol. 2022;361:55-60.
    >> Share

  186. FISCHLEIN T, Caporali E, Folliguet T, Kappert U, et al
    Randomized controlled trial between conventional versus sutureless bioprostheses for aortic valve replacement: Impact of mini and full sternotomy access at 1-year follow-up.
    Int J Cardiol. 2022 Aug 6. pii: S0167-5273(22)01179.
    >> Share

  187. GRAZIANI F, Lillo R, Biagini E, Limongelli G, et al
    Myocardial infarction with non-obstructive coronary arteries in hypertrophic cardiomyopathy vs Fabry disease.
    Int J Cardiol. 2022 Aug 2. pii: S0167-5273(22)01116.
    >> Share

  188. SAVVOULIDIS P, Mechery A, Lawton E, Ludman PF, et al
    Comparison of left ventricular with right ventricular rapid pacing on tamponade during TAVI.
    Int J Cardiol. 2022;360:46-52.
    >> Share

  189. SICARI R
    Diagnosing HCM severity: The role of microvascular impairment.
    Int J Cardiol. 2022;360:44.
    >> Share

    July 2022
  190. LUNARDI M, Venturi G, Del Sole PA, Ruzzarin A, et al
    Optimal timing for percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation.
    Int J Cardiol. 2022 Jul 21. pii: S0167-5273(22)01100.
    >> Share

  191. AUNG H, Eleid MF
    Thrombocytopenia as a marker of poor prognosis following transcatheter aortic valve implantation.
    Int J Cardiol. 2022 Jul 18. pii: S0167-5273(22)01096.
    >> Share

  192. VELY M, L'official G, Galli E, Kosmala W, et al
    Functional tricuspid regurgitation: A clustering analysis and prognostic validation of three echocardiographic phenotypes in an external cohort.
    Int J Cardiol. 2022 Jul 16. pii: S0167-5273(22)01088.
    >> Share

  193. MOOLLA M, Mathew A, John K, Yogasundaram H, et al
    Outcomes of pregnancy in women with hypertrophic cardiomyopathy: A systematic review.
    Int J Cardiol. 2022;359:54-60.
    >> Share

  194. AGUIAR ROSA S, Lopes LR, Branco L, Galrinho A, et al
    Blunted coronary flow velocity reserve is associated with impairment in systolic function and functional capacity in hypertrophic cardiomyopathy.
    Int J Cardiol. 2022;359:61-68.
    >> Share

  195. ALPERI A, Robichaud M, Panagides V, Mesnier J, et al
    Impact of residual transvalvular gradient on clinical outcomes following valve-in-valve transcatheter aortic valve replacement.
    Int J Cardiol. 2022 Jul 4. pii: S0167-5273(22)01024.
    >> Share

  196. DILORENZO MP, DeCost G, Mai AD, Hughes N, et al
    Comparison of serum biomarkers of myocardial fibrosis with cardiac magnetic resonance in patients operated for tetralogy of Fallot.
    Int J Cardiol. 2022;358:27-33.
    >> Share

  197. ALPERI A, Pascual I, Moris C, Avanzas P, et al
    New-generation Ultra and PRO devices: Latest device iterations but old valve type effects.
    Int J Cardiol. 2022;358:83-84.
    >> Share

  198. KIM WK, Renker M, Dorr O, Nef H, et al
    Micro-dislodgement of a self-expanding transcatheter heart valve: Incidence, predictors, and outcomes.
    Int J Cardiol. 2022;358:77-82.
    >> Share

    June 2022
  199. RHEUDE T, Pellegrini C, Allali A, Bleiziffer S, et al
    Multicenter comparison of latest-generation balloon-expandable versus self-expanding transcatheter heart valves: Ultra versus Evolut.
    Int J Cardiol. 2022;357:115-120.
    >> Share

  200. MASCIA G, Crotti L, Groppelli A, Canepa M, et al
    Syncope in hypertrophic cardiomyopathy (part I): An updated systematic review and meta-analysis.
    Int J Cardiol. 2022;357:88-94.
    >> Share

  201. KARDOS A, Rusinaru D, Marechaux S, Alskaf E, et al
    Implementation of a CT-derived correction factor to refine the measurement of aortic valve area and stroke volume using Doppler echocardiography improves grading of severity and prediction of prognosis in patients with severe aortic stenosis.
    Int J Cardiol. 2022 Jun 15. pii: S0167-5273(22)00917.
    >> Share

  202. SOLLI CN, Chamat-Hedemand S, Elming H, Ngo A, et al
    Coronary artery- and aortic valve calcifications in patients with Philadelphia-negative myeloproliferative neoplasms.
    Int J Cardiol. 2022 Jun 15. pii: S0167-5273(22)00928.
    >> Share

  203. MEUCCI MC, Fortuni F, Galloo X, Bootsma M, et al
    Left atrioventricular coupling index in hypertrophic cardiomyopathy and risk of new-onset atrial fibrillation.
    Int J Cardiol. 2022 Jun 15. pii: S0167-5273(22)00916.
    >> Share

  204. LANDES U, Morelli O, Danenberg H, Sathananthan J, et al
    Transcatheter aortic valve-in-valve implantation to treat aortic Para-valvular regurgitation after TAVI.
    Int J Cardiol. 2022 Jun 11. pii: S0167-5273(22)00913.
    >> Share

    May 2022
  205. KE Y, Wang J, Wang W, Guo S, et al
    Antithrombotic strategies after transcatheter aortic valve implantation: A systematic review and network meta-analysis of randomized controlled trials.
    Int J Cardiol. 2022 May 30. pii: S0167-5273(22)00807.
    >> Share

  206. CASTRO-MEJIA AF, Amat-Santos I, Ortega-Armas ME, Baz JA, et al
    Development of atrioventricular and intraventricular conduction disturbances in patients undergoing transcatheter aortic valve replacement with new generation self-expanding valves: A real world multicenter analysis.
    Int J Cardiol. 2022 May 9. pii: S0167-5273(22)00665.
    >> Share

  207. MATSUSHITA K, Marchandot B, Kibler M, Heger J, et al
    P2Y12 inhibition by clopidogrel increases adverse clinical events after transcatheter aortic valve replacement.
    Int J Cardiol. 2022 May 4. pii: S0167-5273(22)00583.
    >> Share

  208. MONDA E, Lioncino M, Palmiero G, Franco F, et al
    Bisoprolol for treatment of symptomatic patients with obstructive hypertrophic cardiomyopathy. The BASIC (bisoprolol AS therapy in hypertrophic cardiomyopathy) study.
    Int J Cardiol. 2022;354:22-28.
    >> Share

    April 2022
  209. SADEGHIPOUR P, Farrashi M, De Caterina R
    Response to "non-vitamin K antagonist oral anticoagulants (NOACs) in preventing thromboembolism in atrial fibrillation patients with moderate to severe mitral stenosis: Results from a pilot trial".
    Int J Cardiol. 2022 Apr 29. pii: S0167-5273(22)00637.
    >> Share

  210. CARBONE RG
    Advancements in calcific aortic valve disease.
    Int J Cardiol. 2022 Apr 22. pii: S0167-5273(22)00568.
    >> Share

  211. PANAGIDES V, Kalavrouziotis D, Dumont E, Delarochelliere R, et al
    Carotid ultrasound following Transcarotid Transcatheter aortic valve replacement.
    Int J Cardiol. 2022 Apr 22. pii: S0167-5273(22)00570.
    >> Share

  212. YALCIN YC, Veenis JF, Brugts JJ, Antonides CFJ, et al
    Rate of thromboembolic and bleeding events in patients undergoing concomitant aortic valve surgery with left ventricular assist device implantation.
    Int J Cardiol. 2022 Apr 16. pii: S0167-5273(22)00555.
    >> Share

  213. ZORZI A, Brunetti G, Corrado D
    Differential diagnosis between athlete's heart and hypertrophic cardiomyopathy: New pieces of the puzzle.
    Int J Cardiol. 2022;353:77-79.
    >> Share

  214. AUTORE C, Ferrazzi P
    Patients with hypertrophic cardiomyopathy are getting older.
    Int J Cardiol. 2022;353:73-74.
    >> Share

  215. BOUREAU AS, Karakachoff M, Le Scouarnec S, Capoulade R, et al
    Heritability of aortic valve stenosis and bicuspid enrichment in families with aortic valve stenosis.
    Int J Cardiol. 2022 Apr 12. pii: S0167-5273(22)00501.
    >> Share

  216. KASTENGREN M, Settergren M, Ruck A, Feldt K, et al
    Percutaneous plug-based vascular closure device in 1000 consecutive transfemoral transcatheter aortic valve implantations.
    Int J Cardiol. 2022 Apr 12. pii: S0167-5273(22)00513.
    >> Share

  217. JOLOBE OMP
    Characteristics of the prothrombotic milieu in mitral stenosis patients managed with direct oral anticoagulants.
    Int J Cardiol. 2022 Apr 10. pii: S0167-5273(22)00509.
    >> Share

  218. LI L, Dai M, Fu Y
    Non-vitamin K antagonist oral anticoagulants (NOACs) in preventing thromboembolism in atrial fibrillation patients with moderate to severe mitral stenosis: Results from a pilot trial.
    Int J Cardiol. 2022 Apr 10. pii: S0167-5273(22)00508.
    >> Share

  219. PANAGIDES V, Mohammadi S, Rodes-Cabau J
    Cranial nerve injury: A word of caution for transcarotid transcatheter aortic valve replacement.
    Int J Cardiol. 2022 Apr 7. pii: S0167-5273(22)00497.
    >> Share

  220. WEGENER A, Holm AE, Gomes LC, Lima KO, et al
    Prevalence of rheumatic heart disease in adults from the Brazilian Amazon Basin.
    Int J Cardiol. 2022;352:115-122.
    >> Share

    March 2022
  221. GOEL A, Malik AH, Gupta R, Rawal H, et al
    Concomitant tricuspid valve repair in patients undergoing mitral valve surgery: A recent update.
    Int J Cardiol. 2022 Mar 16. pii: S0167-5273(22)00388.
    >> Share

  222. SADEGHIPOUR P, Pouraliakbar H, Parsaee M, Shojaeifard M, et al
    RIvaroxaban in mitral stenosis (RISE MS): A pilot randomized clinical trial.
    Int J Cardiol. 2022 Mar 16. pii: S0167-5273(22)00396.
    >> Share

  223. MENNINI FS, Meucci F, Pesarini G, Vandoni P, et al
    Cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in low surgical risk aortic stenosis patients.
    Int J Cardiol. 2022 Mar 16. pii: S0167-5273(22)00393.
    >> Share

  224. MCGRATH D, Zhan Y
    Cranial nerve injury: A word of caution for transcarotid transcatheter aortic valve replacement.
    Int J Cardiol. 2022 Mar 16. pii: S0167-5273(22)00390.
    >> Share

  225. SANTOS-MARTINEZ S, Halim J, Castro-Mejia A, De Marco F, et al
    Myval versus alternative balloon- and self-expandable transcatheter heart valves: A central core lab analysis of conduction disturbances.
    Int J Cardiol. 2022;351:25-31.
    >> Share

  226. ARGIRO A, Rosenblum H, Griffin J, Batra J, et al
    Sex related differences in exercise performance in patients with hypertrophic cardiomyopathy: Hemodynamic insights through non-invasive pressure volume analysis.
    Int J Cardiol. 2022;351:78-83.
    >> Share

  227. TARASOUTCHI F, Rosa VEE
    Rivaroxaban effects on cardiac valve calcifications, renal preservation and inflammatory modulation: Have we found the panacea?
    Int J Cardiol. 2022;351:89-90.
    >> Share

  228. ALBUQUERQUE AM, Brophy JM
    Pacemaker risk following transcatheter aortic valve replacement - A Bayesian reanalysis.
    Int J Cardiol. 2022 Mar 11. pii: S0167-5273(22)00328.
    >> Share

  229. RENKER M, Kim WK
    Assessment of frailty prior to TAVI: Can it now be measured objectively?
    Int J Cardiol. 2022;350:104-105.
    >> Share

  230. WERNER N, Renker M, Dorr O, Bauer T, et al
    Anatomical suitability and off-label use of contemporary transcatheter heart valves.
    Int J Cardiol. 2022;350:96-103.
    >> Share

    February 2022
  231. LIMONGELLI G, Monda E
    Implantable cardioverter defibrillator in hypertrophic cardiomyopathy: Time to avoid unnecessary procedure.
    Int J Cardiol. 2022 Feb 22. pii: S0167-5273(22)00265.
    >> Share

  232. CHARITOS E, Kim WK
    Conduction disturbances following transcatheter aortic valve implantation: Any room for improvement?
    Int J Cardiol. 2022 Feb 16. pii: S0167-5273(22)00252.
    >> Share

  233. MASSERA D, Xia Y, Li B, Riedy K, et al
    Mitral annular calcification in hypertrophic cardiomyopathy.
    Int J Cardiol. 2022;349:83-89.
    >> Share

  234. TABATA N, Tsujita K
    Disparities in transcatheter mitral valve repair - Disparities being corrected little by little?
    Int J Cardiol. 2022 Feb 14. pii: S0167-5273(22)00245.
    >> Share

  235. SALA A, Lorusso R, Alfieri O
    Isolated tricuspid regurgitation: A plea for early correction.
    Int J Cardiol. 2022 Feb 4. pii: S0167-5273(22)00195.
    >> Share

  236. TIRADO-CONTE G, Salazar CH, McInerney A, Cruz-Utrilla A, et al
    Incidence, clinical impact and predictors of thrombocytopenia after transcatheter aortic valve replacement.
    Int J Cardiol. 2022 Feb 3. pii: S0167-5273(22)00198.
    >> Share

    January 2022
  237. PANAGIDES V, Kalavrouziotis D, Dumont E, Delarochelliere R, et al
    Cranial nerve injury during transcarotid transcatheter aortic valve replacement.
    Int J Cardiol. 2022 Jan 31. pii: S0167-5273(22)00187.
    >> Share

  238. YA'QOUB L, Alkhouli M, Elgendy IY
    Symptomatic improvement using the New York Heart Association classification as a predictor for survival after transcatheter edge-to-edge repair of the mitral valve.
    Int J Cardiol. 2022 Jan 23. pii: S0167-5273(22)00132.
    >> Share

  239. REDDAVID C, Costa G, Valvo R, Criscione E, et al
    Transcatheter aortic valve implantation during COVID-19 pandemic: An optimized model to relieve healthcare system overload.
    Int J Cardiol. 2022 Jan 22. pii: S0167-5273(22)00128.
    >> Share

  240. ZHANG C, Liu M, Wang X, Chen S, et al
    Mechanism of CircANKRD36 regulating cell heterogeneity and endothelial mesenchymal transition in aortic valve stromal cells by regulating miR-599 and TGF-beta signaling pathway.
    Int J Cardiol. 2022 Jan 21. pii: S0167-5273(22)00134.
    >> Share

  241. LECLERCQ F, Lorca L, Agullo A, Bouchdoug K, et al
    Evolution of right ventricular dysfunction and tricuspid regurgitation after TAVI: A prospective study.
    Int J Cardiol. 2022 Jan 20. pii: S0167-5273(22)00123.
    >> Share

  242. HASSOUN R, Budde H, Zhazykbayeva S, Herwig M, et al
    Do they come together? Protein quality control, stress-activated signaling, and "sarcostat" in hypertrophic cardiomyopathy progression.
    Int J Cardiol. 2022;347:44-45.
    >> Share

  243. FUMAGALLI C, De Filippo V, Zocchi C, Tassetti L, et al
    Strength of clinical indication and therapeutic impact of the implantable cardioverter defibrillator in patients with hypertrophic cardiomyopathy.
    Int J Cardiol. 2022 Jan 11. pii: S0167-5273(22)00069.
    >> Share

    December 2021
  244. ALPERI A, Pascual I, Moris C, Avanzas P, et al
    Valve type selection for bicuspid aortic valves in TAVR: Does the key lie in the annular size?
    Int J Cardiol. 2021 Dec 31. pii: S0167-5273(21)02049.
    >> Share

  245. SUDO M, Sugiura A, Treiling L, Al-Kassou B, et al
    Baseline PA/BSA ratio in patients undergoing transcatheter aortic valve replacement - A novel CT-based marker for the prediction of pulmonary hypertension and outcome.
    Int J Cardiol. 2021 Dec 16. pii: S0167-5273(21)02011.
    >> Share

  246. NEGRI F, Muser D, Driussi M, Sanna GD, et al
    Prognostic role of global longitudinal strain by feature tracking in patients with hypertrophic cardiomyopathy: The STRAIN-HCM study.
    Int J Cardiol. 2021;345:61-67.
    >> Share

  247. MASCIA G, Olivotto I, Brugada J, Arbelo E, et al
    Sport practice in hypertrophic cardiomyopathy: running to stand still?
    Int J Cardiol. 2021;345:77-82.
    >> Share

  248. ALPERI A, Pascual I, Avanzas P, Moris C, et al
    Atrial-FMR: No longer the forgotten mechanism of functional mitral regurgitation.
    Int J Cardiol. 2021 Dec 14. pii: S0167-5273(21)01999.
    >> Share

  249. HEIDARI B, Ahmad A, Al-Hijji MA, Aoun J, et al
    Muscle fat index is associated with frailty and length of hospital stay following transcatheter aortic valve replacement in high-risk octogenarians.
    Int J Cardiol. 2021 Dec 3. pii: S0167-5273(21)01978.
    >> Share

  250. HASSOUN R, Budde H, Zhazykbayeva S, Herwig M, et al
    Stress activated signalling impaired protein quality control pathways in human hypertrophic cardiomyopathy.
    Int J Cardiol. 2021;344:160-169.
    >> Share

    November 2021
  251. BENFARI G, Cavalcante JL, Enriquez-Sarano M
    Multimodality imaging in functional mitral regurgitation: Valvular disease and the chamber remodeling quantification.
    Int J Cardiol. 2021 Nov 30. pii: S0167-5273(21)01955.
    >> Share

  252. MOSCARELLA E, Mangieri A, Giannini F, Tchetche D, et al
    Annular size and interaction with trans-catheter aortic valves for treatment of severe bicuspid aortic valve stenosis: Insights from the BEAT registry.
    Int J Cardiol. 2021 Nov 26. pii: S0167-5273(21)01871.
    >> Share

  253. RUBBIO AP, Testa L, Grasso C, Sisinni A, et al
    Transcatheter edge-to-edge mitral valve repair in atrial functional mitral regurgitation insights from the multi-center MITRA-TUNE registry.
    Int J Cardiol. 2021 Nov 23. pii: S0167-5273(21)01844.
    >> Share

  254. WENZL FA, Ambrosini S, Paneni F
    Molecular underpinnings of myocardial stiffness in patients with hypertrophic cardiomyopathy.
    Int J Cardiol. 2021;343:80-82.
    >> Share

  255. KHAN U, Shaw T, Kempny A, Gatzoulis MA, et al
    The clinical presentation and outcome of aortic coarctation associated with left ventricular inflow and outflow tract lesion in adult patients: Shone syndrome and beyond.
    Int J Cardiol. 2021;343:45-49.
    >> Share

  256. PFEIFER P, Zietzer A, Holscher M, Jehle J, et al
    Transverse aortic constriction-induced heart failure leads to increased levels of circulating microparticles.
    Int J Cardiol. 2021 Nov 10. pii: S0167-5273(21)01772.
    >> Share

  257. GIORDANO A, Biondi-Zoccai G, Finizio F, Ferraro P, et al
    Characteristics and outcomes of MitraClip in octogenarians: Evidence from 1853 patients in the GIOTTO registry.
    Int J Cardiol. 2021;342:65-71.
    >> Share

    October 2021
  258. HASIN T, Mann D, Welt M, Barrett O, et al
    Loss of left ventricular rotation is a significant determinant of functional mitral regurgitation.
    Int J Cardiol. 2021 Oct 6. pii: S0167-5273(21)01509.
    >> Share

  259. AL-MOHAMMAD A
    The impact of cMR on echocardiographic markers of severe aortic regurgitation, a story of synergy.
    Int J Cardiol. 2021 Oct 5. pii: S0167-5273(21)01503.
    >> Share

  260. BENITO-GONZALEZ T, Carrasco-Chinchilla F, Estevez-Loureiro R, Pascual I, et al
    Clinical and echocardiographic outcomes of transcatheter mitral valve repair in atrial functional mitral regurgitation.
    Int J Cardiol. 2021 Oct 2. pii: S0167-5273(21)01497.
    >> Share

  261. SIONTIS KC, Liu K, Bos JM, Attia ZI, et al
    Detection of hypertrophic cardiomyopathy by an artificial intelligence electrocardiogram in children and adolescents.
    Int J Cardiol. 2021;340:42-47.
    >> Share

    September 2021
  262. FUJITA H, Toba T, Miwa K, Suzuki M, et al
    The impact of computed tomography-derived aortic atheroma volume on prognosis after transcatheter aortic valve replacement.
    Int J Cardiol. 2021 Sep 30. pii: S0167-5273(21)01494.
    >> Share

  263. GEYER M, Keller K, Tamm AR, Born S, et al
    Early symptomatic benefit indicates long-term prognosis after transcatheter mitral valve edge-to-edge repair in functional and degenerative etiology.
    Int J Cardiol. 2021 Sep 23. pii: S0167-5273(21)01479.
    >> Share

  264. MONDA E, Palmiero G, Lioncino M, Rubino M, et al
    External validation of the increased wall thickness score for the diagnosis of cardiac amyloidosis.
    Int J Cardiol. 2021;339:99-101.
    >> Share

  265. PAPANASTASIOU CA, Zegkos T, Kokkinidis DG, Parcharidou D, et al
    Prognostic role of left ventricular apical aneurysm in hypertrophic cardiomyopathy: A systematic review and meta-analysis.
    Int J Cardiol. 2021;339:108.
    >> Share

  266. EL KHOUDARY SR, Fabio A, Yester JW, Steinhauser ML, et al
    Design and rationale of a clinical trial to increase cardiomyocyte division in infants with tetralogy of Fallot.
    Int J Cardiol. 2021;339:36-42.
    >> Share

  267. RODRIGUES T, Raposo SC, Brito D, Lopes LR, et al
    Prognostic relevance of exercise testing in hypertrophic cardiomyopathy. A systematic review.
    Int J Cardiol. 2021;339:83-92.
    >> Share

  268. YA'QOUB L, Jneid H, Elgendy IY
    Transcatheter edge-to-edge repair of the mitral valve: A promising bridge to heart transplant for select patients?
    Int J Cardiol. 2021 Sep 9. pii: S0167-5273(21)01330.
    >> Share

  269. XU YP, Zhang P
    Letter on "Prognostic role of left ventricular apical aneurysm in hypertrophic cardiomyopathy: A systematic review and meta-analysis".
    Int J Cardiol. 2021;338:152.
    >> Share

  270. NAMDAR M, Richardot P, Johner N, Shah D, et al
    Recognition of pre-hypertrophic cardiac involvement in Fabry Disease based on automated electrocardiographic measures.
    Int J Cardiol. 2021;338:121-126.
    >> Share

  271. KAWASHIMA H, Serruys PW, Mylotte D, Rosseel L, et al
    Operator preference and determinants of size selection when additional intermediate-size aortic transcatheter heart valves are made available.
    Int J Cardiol. 2021;338:168-173.
    >> Share

  272. FABI M, Calicchia M, Palleri D, Ndikubwimana I, et al
    Pediatric rheumatic carditis in Italy and Rwanda: The same disease, different socio-economic settings.
    Int J Cardiol. 2021;338:154-160.
    >> Share

  273. BABAPOOR-FARROKHRAN S, Pressman GS
    Mitral annular disjunction: A myocardial abnormality too?
    Int J Cardiol. 2021;338:174-175.
    >> Share

    August 2021
  274. GAO SA, Polte CL, Lagerstrand KM, Bech-Hanssen O, et al
    The usefulness of left ventricular volume and aortic diastolic flow reversal for grading chronic aortic regurgitation severity - Using cardiovascular magnetic resonance as reference.
    Int J Cardiol. 2021 Aug 30. pii: S0167-5273(21)01311.
    >> Share

  275. QIN L, Chen C, Gu S, Zhou M, et al
    A radiomic approach to predict myocardial fibrosis on coronary CT angiography in hypertrophic cardiomyopathy.
    Int J Cardiol. 2021;337:113-118.
    >> Share

    July 2021
  276. WONG I, Sondergaard L, De Backer O
    Computational simulation models to test bioprosthetic aortic valves: A valuable alternative or addition to bench testing?
    Int J Cardiol. 2021 Jul 30. pii: S0167-5273(21)01200.
    >> Share

  277. CATERINAA M, Andreaa R, Pompiliob F
    Aortic valve stenosis burden: Where we are now?
    Int J Cardiol. 2021 Jul 19. pii: S0167-5273(21)01177.
    >> Share

  278. ROBERTS-THOMSON RL, Baumann AAW, Reade J, Culgan L, et al
    Surgical and percutaneous management of Aboriginal Australians with rheumatic heart disease: Timeliness and concordance between practice and guidelines.
    Int J Cardiol. 2021;335:80-84.
    >> Share

  279. HINOJAR R, Gomez AG, Garcia-Martin A, Monteagudo JM, et al
    Impact of right ventricular systolic function in patients with significant tricuspid regurgitation. A cardiac magnetic resonance study.
    Int J Cardiol. 2021 Jul 14. pii: S0167-5273(21)01168.
    >> Share

  280. KAMPAKTSIS PN, Tzoumas A
    LV apical aneurysm in HCM: Implant ICD and anticoagulate?: Editorial comment on: "Prognostic role of left ventricular apical aneurysm in hypertrophic cardiomyopathy: A systematic review and meta-analysis."
    Int J Cardiol. 2021;334:86-87.
    >> Share

  281. WANG TKM, Kwon DH, Abou-Hassan O, Chetrit M, et al
    Strain evaluation for mitral annular disjunction by echocardiography and magnetic resonance imaging: A case-control study.
    Int J Cardiol. 2021;334:154-156.
    >> Share

    June 2021
  282. DOLDI PM, Buech J, Orban M, Samson-Himmelstjerna P, et al
    Transcatheter mitral valve repair may increase eligibility for heart transplant listing in patients with end-stage heart failure and severe secondary mitral regurgitation.
    Int J Cardiol. 2021 Jun 19. pii: S0167-5273(21)01029.
    >> Share

  283. PELLICCIA F, Pasceri V
    The less-is-better effect: The case of alcohol dose in septal ablation for hypertrophic cardiomyopathy.
    Int J Cardiol. 2021;333:143-144.
    >> Share

  284. MARTIN M, Junco-Vicente A, Rodriguez I
    Bicuspid aortopathy in adolescents: Another piece of the puzzle.
    Int J Cardiol. 2021;333:94-95.
    >> Share

  285. NARANG R, Saxena A, Ramakrishnan S, Gupta SK, et al
    An evidence-based scoring system to diagnose acute rheumatic fever with carditis in children.
    Int J Cardiol. 2021;333:146-151.
    >> Share

  286. RODRIGUEZ-GABELLA T, Zimarino M, Barbanti M, Testa L, et al
    Sex based analysis of the impact of red blood cell transfusion and vascular or bleeding complications related to TAVI - The TRITAVI-Women Study.
    Int J Cardiol. 2021;333:69-76.
    >> Share

  287. VESELKA J, Faber L, Liebregts M, Cooper R, et al
    Alcohol dose in septal ablation for hypertrophic obstructive cardiomyopathy.
    Int J Cardiol. 2021;333:127-132.
    >> Share

  288. MOSCARELLI M, Gallo F, Gallone G, Kim WK, et al
    Aortic angle distribution and predictors of horizontal aorta in patients undergoing transcatheter aortic valve replacement.
    Int J Cardiol. 2021 Jun 6. pii: S0167-5273(21)00911.
    >> Share

  289. UY J, Ketkar AG, Portnoy A, Kim JJ, et al
    Cost-utility analysis of heart surgeries for young adults with severe rheumatic mitral valve disease in India.
    Int J Cardiol. 2021 Jun 4. pii: S0167-5273(21)00916.
    >> Share

  290. PAPANASTASIOU CA, Zegkos T, Karamitsos TD, Rowin EJ, et al
    Prognostic role of left ventricular apical aneurysm in hypertrophic cardiomyopathy: A systematic review and meta-analysis.
    Int J Cardiol. 2021;332:127-132.
    >> Share

  291. MAGRI D, Gallo G
    Cardiopulmonary exercise testing: An increasingly important step in managing hypertrophic cardiomyopathy.
    Int J Cardiol. 2021;332:138-139.
    >> Share

  292. SARRAJ-ASIL A, Diez-Villanueva P
    Insight into functional tricuspid valve regurgitation pathogenesis, pathological stages, and surgical management.
    Int J Cardiol. 2021 Jun 1. pii: S0167-5273(21)00903.
    >> Share

    May 2021
  293. VON KAPPELGAARD L, Gislason G, Davidsen M, Zwisler AD, et al
    Temporal trends and socioeconomic differences in treatment and mortality following a diagnosis of aortic stenosis.
    Int J Cardiol. 2021 May 27. pii: S0167-5273(21)00896.
    >> Share

  294. WANG Z, Zhao L, He S
    Prognostic nutritional index and the risk of mortality in patients with hypertrophic cardiomyopathy.
    Int J Cardiol. 2021;331:152-157.
    >> Share

  295. SEGGEWISS H, Batzner A
    Surgical myectomy in HOCM: Still gold standard for septal reduction?
    Int J Cardiol. 2021;331:174-175.
    >> Share

  296. TOME ESTEBAN MT
    Gender disease-dose in hypertrophic cardiomyopathy.
    Int J Cardiol. 2021;331:172-173.
    >> Share

  297. D'ASCENZO F, Bruno F, Baldetti L, De Filippo O, et al
    Aortic valve replacement vs. balloon-expandable and self-expandable transcatheter implantation: A network meta-analysis.
    Int J Cardiol. 2021 May 8. pii: S0167-5273(21)00811.
    >> Share

  298. OOMS JF, Ceusters J, Hirsch A, Budde RPJ, et al
    Accuracy of three-dimensional computational modeling in prediction of the dynamic neo left ventricular outflow tract with transcatheter mitral valve replacement.
    Int J Cardiol. 2021 May 6. pii: S0167-5273(21)00814.
    >> Share

  299. VILADES D, Garcia-Moll X, Gomez-Llorente M, Pujadas S, et al
    Differentiation of athlete's heart and hypertrophic cardiomyopathy by the fractal dimension of left ventricular trabeculae.
    Int J Cardiol. 2021;330:232-237.
    >> Share

  300. MUKAI K
    Cardiac magnetic resonance T1 mapping: A novel quality assurance program paving the way towards standardization and wider clinical practice.
    Int J Cardiol. 2021;330:266-267.
    >> Share

  301. YAMAMURA K, Duarte V, Karur GR, Graf J, et al
    The impact of pulmonary valve replacement on pregnancy outcomes in women with tetralogy of Fallot.
    Int J Cardiol. 2021;330:43-49.
    >> Share

  302. ZHANG Q, Werys K, Popescu IA, Biasiolli L, et al
    Quality assurance of quantitative cardiac T1-mapping in multicenter clinical trials - A T1 phantom program from the hypertrophic cardiomyopathy registry (HCMR) study.
    Int J Cardiol. 2021;330:251-258.
    >> Share

  303. XU F, Chen Y, Tillman KA, Cui Y, et al
    Characterizing modifier genes of cardiac fibrosis phenotype in hypertrophic cardiomyopathy.
    Int J Cardiol. 2021;330:135-141.
    >> Share

    April 2021
  304. TRIMAILLE A, Hmadeh S, Matsushita K, Schini-Kerth V, et al
    Reply to "Patients with aortic stenosis exhibit early improved endothelial function following transcatheter aortic valve replacement: The eFAST study" by Comella et al.
    Int J Cardiol. 2021 Apr 29. pii: S0167-5273(21)00747.
    >> Share

  305. LI C, Tang D, Yao J, Shao Y, et al
    Porcine and bovine aortic valve comparison for surgical optimization: A fluid-structure interaction modeling study.
    Int J Cardiol. 2021 Apr 28. pii: S0167-5273(21)00740.
    >> Share

  306. DEKANY G, Fontos G, Satish S, Szabo G, et al
    The prognostic value of immediate post-TAVI hemodynamic evaluation is superior to aortography and transoesophageal echocardiography in predicting patient survival.
    Int J Cardiol. 2021;329:153-161.
    >> Share

  307. MIDTBO H, Hauge SW, Haaverstad R, Dalen H, et al
    How reproducible is the diagnosis of borderline rheumatic heart disease?
    Int J Cardiol. 2021;328:163-164.
    >> Share

  308. BATZNER A, Aicha D, Pfeiffer B, Neugebauer A, et al
    Sex-related differences in symptomatic patients with hypertrophic obstructive cardiomyopathy - Time for a new definition?
    Int J Cardiol. 2021;328:117-121.
    >> Share

  309. PRADEGAN N, Leon-Wyss JR, Iribarren JR, Garcia E, et al
    Contemporary trends in surgical rheumatic valve disease in a Caribbean nation.
    Int J Cardiol. 2021;328:215-217.
    >> Share

  310. KHARBANDA RK, Lodder L, Ragab AAY, de Jong PL, et al
    Early and late post-operative arrhythmias after surgical myectomy: 45 years of follow-up.
    Int J Cardiol. 2021;328:63-68.
    >> Share

    March 2021
  311. GIANNINI C, Angelillis M, Fiorina C, Tamburino C, et al
    Clinical impact and evolution of mitral regurgitation after TAVI using the new generation self-expandable valves.
    Int J Cardiol. 2021 Mar 31. pii: S0167-5273(21)00630.
    >> Share

  312. DE MARZO V, Dettori S, Nicolini LA, Vercellino M, et al
    Early infections after successful transcatheter aortic valve replacement are associated with increased short- and long-term mortality: A single-center study.
    Int J Cardiol. 2021 Mar 27. pii: S0167-5273(21)00622.
    >> Share

  313. OH JK, Lee SH, Lee SA, Kang DY, et al
    Prognostic impact of left ventricular mass regression after transcatheter aortic valve replacement in patients with left ventricular hypertrophy.
    Int J Cardiol. 2021 Mar 26. pii: S0167-5273(21)00557.
    >> Share

  314. KIM WK, Doerr O, Renker M, Choi YH, et al
    Initial experience with a novel, modular, minimalistic approach for transfemoral aortic valve implantation.
    Int J Cardiol. 2021 Mar 26. pii: S0167-5273(21)00564.
    >> Share

  315. COMELLA A, Michail M, Chan J, Cameron JD, et al
    Patients with aortic stenosis exhibit early improved endothelial function following transcatheter aortic valve replacement: The eFAST study.
    Int J Cardiol. 2021 Mar 26. pii: S0167-5273(21)00566.
    >> Share

  316. LLOYD JW, Eleid MF
    Simplifying the approach to classical low-flow low-gradient severe aortic stenosis: A renewed emphasis on the resting transthoracic echocardiogram.
    Int J Cardiol. 2021 Mar 22. pii: S0167-5273(21)00547.
    >> Share

  317. SIURANA JM, Sabate-Rotes A, Ayerza A, Jimenez L, et al
    Adolescents with bicuspid aortic valve: Which criteria should we use for aortic dilatation?
    Int J Cardiol. 2021 Mar 20. pii: S0167-5273(21)00545.
    >> Share

  318. JOSEPH N, Craft M, Mill L, Erickson CC, et al
    Assessment of mitral valve function in children and young adults with hypertrophic cardiomyopathy using three-dimensional echocardiography.
    Int J Cardiol. 2021 Mar 19. pii: S0167-5273(21)00544.
    >> Share

  319. AMAT-SANTOS IJ, Barrero A
    New conduction abnormalities following aortic valve-in-valve: The weakest link of a strong chain.
    Int J Cardiol. 2021 Mar 18. pii: S0167-5273(21)00478.
    >> Share

  320. MANCONE M, Infusino F, Fedele F, Sardella G, et al
    Transcervical approach for TAVI: Perhaps more than a fallback.
    Int J Cardiol. 2021;327:66-67.
    >> Share

  321. SCOLARI FL, Faganello LS, Garbin HI, Piva E Mattos B, et al
    A systematic review of microRNAs in patients with hypertrophic cardiomyopathy.
    Int J Cardiol. 2021;327:146-154.
    >> Share

  322. KOCHAV SM, Raita Y, Fifer MA, Takayama H, et al
    Predicting the development of adverse cardiac events in patients with hypertrophic cardiomyopathy using machine learning.
    Int J Cardiol. 2021;327:117-124.
    >> Share

  323. BERNARD J, Tastet L, Capoulade R, Shen M, et al
    Left ventricular asymmetric remodeling and subclinical left ventricular dysfunction in patients with calcific aortic valve stenosis - Results from a subanalysis of the PROGRESSA study.
    Int J Cardiol. 2021 Mar 13. pii: S0167-5273(21)00474.
    >> Share

  324. HOKKEN TW, van Wiechen MP, Ooms JF, El Azzouzi I, et al
    Impact of Interventricular membranous septum length on pacemaker need with different Transcatheter aortic valve implantation systems.
    Int J Cardiol. 2021 Mar 3. pii: S0167-5273(21)00391.
    >> Share

  325. KELLERMAIR J, Saeed S, Chambers JB, Kammler J, et al
    Predictors of true-severe classical low-flow low-gradient aortic stenosis at resting echocardiography.
    Int J Cardiol. 2021 Mar 1. pii: S0167-5273(21)00381.
    >> Share

    February 2021
  326. XIE MY, Hou LJ
    LncRNA MALAT1 aggravates calcific aortic valve disease by sponging miR-195.
    Int J Cardiol. 2021 Feb 26. pii: S0167-5273(21)00370.
    >> Share

  327. KRALER S, Wenzl FA, Akhmedov A, Blaser MC, et al
    ApoA-I mimetics improve aortic stenosis-associated left-ventricular diastolic dysfunction but fail to benefit rabbit models with normal aortic valves.
    Int J Cardiol. 2021 Feb 21. pii: S0167-5273(21)00297.
    >> Share

  328. AKODAD M, Aldhaheri E, Marin G, Roubille F, et al
    Transcatheter aortic valve replacement performed with selective telemetry monitoring: A prospective study.
    Int J Cardiol. 2021 Feb 20. pii: S0167-5273(21)00281.
    >> Share

  329. TENGLER A, Ulrich S, Fischer M, Pastor-Villaescusa B, et al
    Rationale and feasibility of transcatheter pulmonary valve implantation in small conduits with the Edwards Sapien valves.
    Int J Cardiol. 2021;325:45-50.
    >> Share

  330. STANKOWSKI T, Mangner N, Linke A, Aboul-Hassan SS, et al
    Cardiac conduction abnormalities in patients with degenerated bioprostheses undergoing transcatheter aortic valve-in-valve implantations and their impact on long-term outcomes.
    Int J Cardiol. 2021 Feb 13. pii: S0167-5273(21)00282.
    >> Share

  331. FIDOCK B, Archer G, Barker N, Elhawaz A, et al
    Standard and emerging CMR methods for mitral regurgitation quantification.
    Int J Cardiol. 2021 Feb 3. pii: S0167-5273(21)00148.
    >> Share

    January 2021
  332. WANG H, Song H, Yang Y, Wu Z, et al
    Morphology display and hemodynamic testing using 3D printing may aid in the prediction of LVOT obstruction after mitral valve replacement.
    Int J Cardiol. 2021 Jan 31. pii: S0167-5273(21)00110.
    >> Share

  333. LUQUE T, Noriega FJ, McInerney A, Travieso A, et al
    Impact of delirium in acute cardiac care unit after transcatheter aortic valve replacement.
    Int J Cardiol. 2021 Jan 30. pii: S0167-5273(21)00135.
    >> Share

  334. REIFART J, Liebetrau C, Weferling M, Dorr O, et al
    Single versus double use of a suture-based closure device for transfemoral aortic valve implantation.
    Int J Cardiol. 2021 Jan 30. pii: S0167-5273(21)00125.
    >> Share

  335. ANDO T, Onishi T, Tobaru T
    Extremely severe aortic stenosis - Is TAVR the answer?
    Int J Cardiol. 2021 Jan 28. pii: S0167-5273(21)00085.
    >> Share

  336. VALLABHAJOSYULA S, Vallabhajosyula S, Yang LT, Rabinstein AA, et al
    Frequency of intracranial aneurysms and sub-arachnoid hemorrhage is significantly lesser in bicuspid aortic valve than aortic coarctation.
    Int J Cardiol. 2021 Jan 28. pii: S0167-5273(21)00127.
    >> Share

  337. KOFFLARD MJM
    Pacing in hypertrophic obstructive cardiomyopathy: First choice therapy in low volume centers?
    Int J Cardiol. 2021;323:199-200.
    >> Share

  338. DORSCH LM, Kuster DWD, Jongbloed JDH, Boven LG, et al
    The effect of tropomyosin variants on cardiomyocyte function and structure that underlie different clinical cardiomyopathy phenotypes.
    Int J Cardiol. 2021;323:251-258.
    >> Share

  339. HUURMAN R, Schinkel AFL, de Jong PL, van Slegtenhorst MA, et al
    Impact of sex on timing and clinical outcome of septal myectomy for obstructive hypertrophic cardiomyopathy.
    Int J Cardiol. 2021;323:133-139.
    >> Share

  340. KONECNY T, Khoo M, Covassin N, Edelhofer P, et al
    Increased heart rate with sleep disordered breathing in hypertrophic cardiomyopathy.
    Int J Cardiol. 2021;323:155-160.
    >> Share

  341. NACHAR W, Merlet N, Maafi F, Mihalache-Avram T, et al
    ApoA-I mimetic does not improve left ventricular diastolic dysfunction in rabbits without aortic valve stenosis.
    Int J Cardiol. 2021 Jan 6. pii: S0167-5273(20)34337.
    >> Share

  342. SAJI M, Higuchi R, Izumi Y, Takamisawa I, et al
    Transcatheter aortic valve replacement in patients with extremely severe aortic stenosis.
    Int J Cardiol. 2021 Jan 5. pii: S0167-5273(20)34328.
    >> Share

  343. MICELI A, Di Bacco L, Donatelli F, Glauber M, et al
    Can we solve two problems with a TAVR?
    Int J Cardiol. 2021;322:95-96.
    >> Share

  344. JAVIDGONBADI D, Andersson B, Abdon NJ, Ostman-Smith I, et al
    Morbidity and resource usage after myectomy- or pacing-treatment in hypertrophic obstructive cardiomyopathy: A case-control study.
    Int J Cardiol. 2021;322:197-203.
    >> Share

  345. RYU AJ, Kumar V, Borlaug BA, Manduca A, et al
    Systolic-to-diastolic myocardial volume ratio as a novel imaging marker of cardiomyopathy.
    Int J Cardiol. 2021;322:272-277.
    >> Share

    December 2020
  346. IACOVELLI F, Pignatelli A, Cafaro A, Stabile E, et al
    Impact of contrast medium osmolality on the risk of acute kidney injury after transcatheter aortic valve implantation: Insights from the magna Graecia TAVI registry.
    Int J Cardiol. 2020 Dec 23. pii: S0167-5273(20)34297.
    >> Share

  347. KHERALLAH RY, Harrison D, Preventza O, Silva GV, et al
    Transcatheter aortic valve replacement after chest radiation: A propensity-matched analysis.
    Int J Cardiol. 2020 Dec 22. pii: S0167-5273(20)34302.
    >> Share

  348. USUKU H, Yamamoto E, Noguchi M, Komorita T, et al
    Elevated C-reactive protein is significantly associated with left ventricular dysfunction in patients with aortic regurgitation and concomitant collagen disease.
    Int J Cardiol. 2020 Dec 22. pii: S0167-5273(20)34301.
    >> Share

  349. ALI FM, Ong G, Edwards J, Connelly KA, et al
    Comparison of transcatheter tricuspid valve repair using the MitraClip NTR and XTR systems.
    Int J Cardiol. 2020 Dec 7. pii: S0167-5273(20)34244.
    >> Share

  350. TRIPATHI B, Sawant AC, Sharma P, Tandon V, et al
    Short term outcomes after transcatheter mitral valve repair.
    Int J Cardiol. 2020 Dec 2. pii: S0167-5273(20)34219.
    >> Share

    November 2020
  351. PASCANER AF, Houriez-Gombaud-Saintonge S, Craiem D, Gencer U, et al
    Comprehensive assessment of local and regional aortic stiffness in patients with tricuspid or bicuspid aortic valve aortopathy using magnetic resonance imaging.
    Int J Cardiol. 2020 Nov 28. pii: S0167-5273(20)34169.
    >> Share

  352. LU H, Monney P, Fournier S, Pavon AG, et al
    Transcervical approach versus transfemoral approach for transcatheter aortic valve replacement.
    Int J Cardiol. 2020 Nov 23. pii: S0167-5273(20)34149.
    >> Share

  353. CHENG YY, Chow V, Brieger D, Yan TD, et al
    Outcomes of 16,436 patients requiring isolated aortic valve surgery: A statewide cohort study.
    Int J Cardiol. 2020 Nov 9. pii: S0167-5273(20)34084.
    >> Share

  354. MONDA E, Limongelli G
    The hospitalizations in hypertrophic cardiomyopathy: "The dark side of the moon".
    Int J Cardiol. 2020;318:101-102.
    >> Share

  355. MAOR E, Barbash IM
    TAVR review of reviews: A new view on the horizon.
    Int J Cardiol. 2020;318:43-44.
    >> Share

    October 2020
  356. IELASI A, Moscarella E, Mangieri A, Giannini F, et al
    Procedural and clinical outcomes of type 0 versus type 1 bicuspid aortic valve stenosis undergoing trans-catheter valve replacement with new generation devices: Insight from the BEAT international collaborative registry.
    Int J Cardiol. 2020 Oct 22. pii: S0167-5273(20)34003.
    >> Share

  357. ANDO T, Adegbala O, Aggarwal A, Afonso L, et al
    Redo aortic valve intervention after transcatheter aortic valve replacement: Analysis of the nationwide readmission database.
    Int J Cardiol. 2020 Oct 22. pii: S0167-5273(20)33991.
    >> Share

  358. ZHANG Y, Fan P, Zhang H, Ma W, et al
    Clinical characteristics and outcomes of chronic heart failure in adult Takayasu arteritis: A cohort study of 163 patients.
    Int J Cardiol. 2020 Oct 18. pii: S0167-5273(20)33984.
    >> Share

  359. LESSICK J
    Is CMR the gold standard for evaluating transvalvular flow?
    Int J Cardiol. 2020;317:221-222.
    >> Share

  360. JENSEN JK, Poulsen SH
    Left atrial systolic function by strain analysis - A new useful prognostic tool in primary severe mitral regurgitation?
    Int J Cardiol. 2020 Oct 6. pii: S0167-5273(20)33911.
    >> Share

  361. YILDIRIM OT, Ozgeyik M, Ozgeyik MO
    Safety of transcatheter aortic valve replacement at malignancy patients.
    Int J Cardiol. 2020 Oct 4. pii: S0167-5273(20)33907.
    >> Share

    June 2020
  362. MATHEW J, Nguyen A, Nishimura RA, Geske JB, et al
    Septal Myectomy in patients with previous coronary revascularization - hypertrophic cardiomyopathy masquerading as ischemic heart disease.
    Int J Cardiol. 2020 Jun 19. pii: S0167-5273(20)33393.
    >> Share

    April 2020
  363. CHEN Y, O'Mahony C
    The price and value of implantable cardioverter defibrillators in hypertrophic cardiomyopathy.
    Int J Cardiol. 2020 Apr 2. pii: S0167-5273(20)30939.
    >> Share

    February 2020
  364. MAGNUSSON P, Wimo A
    Health economic evaluation of implantable cardioverter defibrillators in hypertrophic cardiomyopathy in adults.
    Int J Cardiol. 2020 Feb 20. pii: S0167-5273(19)35600.
    >> Share

  365. KALBACHER D, Daubmann A, Tigges E, Hunlich M, et al
    Impact f pre- and post-procedural renal dysfunction on long-term outcomes in patients undergoing MitraClip implantation: A retrospective analysis from two German high-volume centres.
    Int J Cardiol. 2020;300:87-92.
    >> Share

  366. MAURIZI N, Rella V, Fumagalli C, Salerno S, et al
    Prevalence of cardiac amyloidosis among adult patients referred to tertiary centres with an initial diagnosis of hypertrophic cardiomyopathy.
    Int J Cardiol. 2020;300:191-195.
    >> Share

    January 2020
  367. YANG H, Bouma BJ, Dimopoulos K, Khairy P, et al
    Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide study.
    Int J Cardiol. 2020;299:123-130.
    >> Share

  368. LIMONGELLI G, Monda E, Tramonte S, Gragnano F, et al
    Prevalence and clinical significance of red flags in patients with hypertrophic cardiomyopathy.
    Int J Cardiol. 2020;299:186-191.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016